GenSight Biologics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.42	2.46	2.13	10.61	44.29
Cash & Short-Term Investments	2.42	2.46	2.13	10.61	44.29
Cash Growth	-1.99%	15.46%	-79.89%	-76.04%	16.72%
Accounts Receivable	-	0	0	-	0.75
Other Receivables	1.58	1.99	2.4	3.49	3.54
Receivables	1.58	1.99	2.4	3.49	4.3
Prepaid Expenses	0.15	0.28	1.63	8.21	2.55
Other Current Assets	0.84	0.61	0.37	0.63	2.23
Total Current Assets	4.98	5.34	6.53	22.95	53.36
Property, Plant & Equipment	0.43	0.93	2.03	2.27	2.55
Other Intangible Assets	-	0.06	0.08	0.09	0.11
Other Long-Term Assets	2.85	4.42	0.5	0.63	0.62
Total Assets	8.26	10.76	9.13	25.94	56.65
Accounts Payable	5.92	6.36	5.63	7.81	11.56
Accrued Expenses	2.14	1.73	1.79	3.61	2.45
Current Portion of Long-Term Debt	3.3	13.31	16.61	1.54	4.68
Current Portion of Leases	0.35	0.59	0.78	0.89	0.74
Current Income Taxes Payable	0.25	0.17	0.03	0.03	0.02
Current Unearned Revenue	-	-	0.07	0.03	0.2
Other Current Liabilities	0.72	0.46	0.4	0.73	2.6
Total Current Liabilities	12.67	22.62	25.29	14.64	22.24
Long-Term Debt	9.22	-	5.11	14.46	10.58
Long-Term Leases	0	0.51	1.05	0.97	1.51
Long-Term Unearned Revenue	-	-	-	0.19	0.42
Pension & Post-Retirement Benefits	1.1	1.17	1.26	0.02	0.04
Other Long-Term Liabilities	10.2	13.38	7.13	10.93	5.86
Total Liabilities	33.2	37.68	39.83	41.22	40.66
Common Stock	5.52	3.12	1.63	1.16	1.16
Additional Paid-In Capital	217.41	206.61	190.94	181.21	181.18
Retained Earnings	-12.04	-14	-26.22	-27.63	-28.62
Comprehensive Income & Other	-235.83	-222.64	-197.05	-170.02	-137.73
Shareholders' Equity	-24.94	-26.92	-30.7	-15.28	15.99
Total Liabilities & Equity	8.26	10.76	9.13	25.94	56.65
Total Debt	12.86	14.41	23.54	17.86	17.51
Net Cash (Debt)	-10.45	-11.95	-21.4	-7.25	26.78
Net Cash Growth	-	-	-	-	42.36%
Net Cash Per Share	-0.07	-0.12	-0.44	-0.16	0.59
Filing Date Shares Outstanding	220.32	128.15	64.97	46.18	46.24
Total Common Shares Outstanding	220.32	128.15	64.97	46.18	46.24
Working Capital	-7.69	-17.28	-18.76	8.31	31.12
Book Value Per Share	-0.11	-0.21	-0.47	-0.33	0.35
Tangible Book Value	-24.94	-26.98	-30.78	-15.37	15.88
Tangible Book Value Per Share	-0.11	-0.21	-0.47	-0.33	0.34
Machinery	1.23	1.23	1.23	1.22	1.36
Leasehold Improvements	1.31	1.38	1.35	1.37	0.98

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.